Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), ...
Since it was launched in November of last year, Phylo has helped to supply researchers with more than 350,000 solutions to DNA problems Over the past year our genetic understanding of diseases such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results